New therapeutic targets to reduce inflammation-associated cardiovascular risk: the CCL2-CCR2 axis, LOX-1, and IRF5.

Subjects

Subjects :

Chemokine CCL2 metabolism
Heart Disease Risk Factors
Humans
Inflammation
Interferon Regulatory Factors
Receptors, CCR2 metabolism
Risk Factors
Scavenger Receptors, Class E
Cardiovascular Diseases etiology
Cardiovascular Diseases prevention & control

Details

Language :

English

ISSN :

1522-9645

Volume :

43

Issue :

19

Database :

MEDLINE

Journal :

European heart journal

Publication Type :

Academic Journal

Accession number :

35567553

Full Text :

https://doi.org/10.1093/eurheartj/ehac233